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Introduction: In post-dilution online haemodiaﬁltration (OL-HDF), the only recommendation
concerning the dialysate, or dialysis ﬂuid, refers to its purity. No study has yet determined
whether using a high dialysate ﬂow (Qd) is useful for increasing Kt or ultraﬁltration-infusion
volume.
Objective: Study the inﬂuence of Qd on Kt and on infusion volume in OL-HDF.
Material and methods: This was a prospective crossover study. There were 37 patients to
whom 6 sessions of OL-HDF were administered at 3 different Qds: 500, 600 and 700 mL/min.
A  5008® monitor was used for the dialysis in 21 patients, while an AK-200® was used in
17.  The dialysers used were: 20 with FX 800® and 17 with Polyﬂux-210®. The rest of the
parameters were kept constant. Monitor data collected were effective blood ﬂow, effective
dialysis time, ﬁnal Kt and infused volume.
Results: We  found that using a Qd of 600 or 700 mL/min increased Kt by 1.7% compared to
using a Qd of 500 mL/min. Differences in infusion volume were not signiﬁcant. Increasing
Qd  from 500 mL/min to 600 and 700 mL/min increased dialysate consumption by 20% and
40%,  respectively.
Conclusions: With the monitors and dialysers currently used in OL-HDF, a Qd higher than
500  mL/min is unhelpful for increasing the efﬁcacy of Kt or infusion volume. Consequently,
using a high Qd wastes water, a truly important resource both from the ecological and
economic points of view.© 2015 Sociedad Espan˜ola de Nefrología. Published by Elsevier España, S.L.U. This is an
open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).
 Please cite this article as: Albalate Ramón M, de Sequera Ortiz P, Pérez-García R, Corchete Prats E, Alcázar Arroyo R, Ortega Díaz M,
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¿Cuál  es  el  ﬂujo  de  ban˜o  óptimo  en  la  hemodiaﬁltración  on-line
posdilucional?
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Flujo de infusión
r  e  s  u  m  e  n
Introducción: En la hemodiaﬁltración en línea posdilucional (HDFOL) la única recomendación
acerca del líquido de diálisis (LD) hace referencia a su pureza. No se ha deﬁnido si usar
ﬂujos de ban˜o (Qd) elevados tiene alguna utilidad para aumentar el Kt o el volumen de
ultraﬁltración-infusión (VI).
Objetivo: Estudiar cómo inﬂuye el Qd en el Kt y en el VI en la HDFOL.
Material y métodos: Estudio cruzado prospectivo. Se incluyó a 37 pacientes a los que se les
realizaron 6 sesiones de HDFOL con cada Qd: 500, 600 y 700 ml/min. Veintiún pacientes se
dializaron en monitor 5008® y 17 con AK-200®. Los dializadores utilizados fueron: 20 con
FX800® y 17 con Polyﬂux-210®. El resto de los parámetros se mantuvieron constantes. Se
recogieron del monitor: ﬂujo efectivo de sangre, tiempo efectivo de diálisis, Kt ﬁnal y VI.
Resultados: Encontramos que usando un Qd = 600 o 700 ml/min, el Kt aumentó un 1,7%
respecto al uso de Qd = 500 ml/min. Las diferencias de VI no fueron signiﬁcativas.
Aumentar el Qd de 500 ml/min a 600 y 700 ml/min aumenta el consumo de LD un 20 y un
40%, respectivamente.
Conclusiones: En la HDFOL con los monitores y dializadores utilizados no son útiles los Qd
superiores a 500 ml/min para aumentar la eﬁcacia del Kt ni el VI, por lo que su utilización
implica un despilfarro de un recurso como el agua, tan importante tanto desde el punto de
vista  ecológico como económico.
© 2015 Sociedad Espan˜ola de Nefrología. Publicado por Elsevier España, S.L.U. Este es un
artículo Open Access bajo la licencia CC BY-NC-NDPost-dilutional online haemodiaﬁltration (OL-HDF) is a
technique of replacement therapy with some advantages
as compared to haemodialysis (HD), including: improved
haemodynamic stability, better responses to erythropoiesis-
stimulating agents and to the growth hormone in chil-
dren, higher clearance of phosphates and 2-microglobulin,
decreased incidence of dialysis related amyloidosis and reduc-
tion of markers/mediators of chronic inﬂammation, improved
nutritional status and better preservation residual renal func-
tion (RRF), improvement response of liver encephalopathy,
and a higher survival rate as shown in recent studies.1 This
technique utilises dialysis ﬂuid (ultrapure) for reposition and,
even though it may be cost-effective,2 the use of this technique
is limited by the need for a large volume of dialysate.
Kt/V or Kt are used in HD to control the dialysis dose
based on minimum levels below which mortality is increased.
Clinical guidelines recommend a minimum Kt/V of 1.2 or a
urea reduction ratio of 65%, but different HD monitors have
non-invasive built-in biosensors to measure effective ionic
dialysance, which is equivalent to the clearance of urea (K).
These sensors calculate the dose of dialysis with no additional
analytical determinations or additional costs; it also avoids
the bias associated to the inclusion of V (volume of distribu-
tion of urea) and provides a real measurement of the dose of
dialysis in each session dialysis given in each session. In 1999
Lowrie et al. suggested that Kt was a marker of the dialysis
dose and mortality and recommended that the minimal Kt
should be 40–45 L for women and 45–50 for men.3 In a study
of 3009 patients, a high Kt was associated with increased sur-
vival; it was recommended to adjust Kt for the body surface
area (BSA), which is a demanding strategy.4 It si not clear(http://creativecommons.org/licenses/by-nc-nd/4.0/).
if the dose of dialysis is the same in OL-HDF as in other
replacement therapies. However the dialysis targets should
be the same for patients on OL-HDF and HD patients unless
other evidence becomes available. In addition, several studies
have shown that the amount of convective volume seems to
be critical for improvement of survival. Convective volumes
were: 15 L/session in the European Dialysis Outcomes and
Practice Pattern Study (DOPPS),5 17.4 L/session in the Turkish
study,6 21.9 L in the Convective Transport Study (CONTRAST),7
and 23.1 L in the Online Haemodiaﬁltration Survival Study
(ESHOL).8 These studies documented the necessity to achieve
high convective volumes to reduce mortality. Therefore we  set
a target volume above 24 L, to comply with the highest quality
standard.
The dialysis dose (or Kt) depends on the dialyser KoA, ﬂow
rate conditions (blood [Qb], dialysis ﬂuid [Qd], and ultraﬁl-
tration), and dialysis time. Studies conducted in the 1990s
found that KoA and clearance may be enhanced by increas-
ing Qd.9,10 Results from these studies led to the increase in
Qd to 700–800 mL/min in an attempt to improve clearance.
However, during the last years, the performance of dialysers
has been improved after application of changes in the design
(ﬁbre crossing with a certain angle, ﬁbre undulations, changes
in ﬁbre packing density and different ﬂow distributors at the
entrance and exit of dialysate compartments).11–13 Therefore,
recent papers have shown that when using these new dialy-
sers an increase of Qd has virtually no effect in HD efﬁcacy.14–18
However it is not known whether these observations can be
extrapolated to OL-HDF. We  have not found studies dedicated
to evaluate the effect of different Qds on OL-HDF, and therefore
it is not known which is an optimal Qd in OL-HDF as assessed
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y its effects on Kt or VI. An elevated Qd results in high con-
umption of water and dialysate concentrates. High Qd should
e used only if Kt or VI are improved. Water conservation is
art of the overall plan for protection of natural resources, an
ssue that cannot be ignored by our society. Water is a dwin-
ling commodity in many  places throughout the world, and
ven though HD facilities should be careful of its consumption,
arge volumes of water are often wasted.19 Several alternatives
or improvement have been proposed including recycling the
ejected water, but preventing the misuse of water is certainly
he ﬁrst and basic step. Determining the optimal Qd in OL-
DF becomes an elementary target for more  rational water
onsumption. In this study our aim is to examine the effect of
d on Kt and VI in OL-HDF.
bjectives
. To assess the effect of Qd (500, 600, and 700 mL/min) in Kt
and VI in OL-HDF.
. To quantify the amount of water that can be saved.
aterial  and  methods
his is a prospective cross-over study conducted in a single
ialysis facility. Subjects had to be older than 18 years and on
L-HDF for more  than 3 months.
Demographics data included: sex, age, time in HD, and aeti-
logy of renal disease. The Kt objective (Ktobj) was individually
djusted for BSA.
Thirty-seven patients were enrolled (16 women and 21
en). Monitors and dialysers were the same throughout the
tudy. A total of 16 patients were dialysed with AK 200® and 21
ith Fresenius 5008®. The membranes used were distributed
s follows: 20 FX800® and 17 Polyﬂux 210H®. All patients
nderwent OL-HDF as shown below:
 6 sessions at Qd of 500 mL/min.
 6 sessions at Qd of 600 mL/min.
 6 sessions at Qd of 700 mL/min.
Dialysis time, anticoagulation, and blood ﬂow rate were
nchanged throughout the entire study period. Ultraﬁltra-
ion volumes were adjusted according to individual clinical
equirements. When recirculation is measured by 5008®, there
s a temporal increase of Qd to 800 mL/min.; recirculation was
outinely measured once in the session.
The following parameters were directly recorded from the
onitor display: effective blood ﬂow rate (Qbe), Qd, effective
ime in dialysis, ﬁnal Kt (Ktf), and ﬁnal VI.
Based on the collected data the following parameters were
alculated:
. Mean individual values of Qbe, effective time in dialysis, VI,
and Ktf at each Qd.
. Kt differences: Ktobj − Ktf.
. VI differences (target = 24 L): VIobj − ﬁnal VI.(6):533–538 535
Statistics
Qualitative variables are expressed as percentages and quan-
titative variables as means (standard deviation) or medians
(minimum − maximum). Quantitative variables were com-
pared by Paired t tests and ANOVA while. Chi-square tests
were used to compare qualitative variables. A p value below
0.05 was considered statistically signiﬁcant.
Analyses were conducted using the software SPSS version
15.0.
Results
The median age of the 37 patients enrolled was 67.4 years
(36–92). The aetiology of CKD was: diabetes mellitus in 13,
glomerular disease in 7, unknown in 6, vascular origin in
5, interstitial disease in 4, and polycystic kidney disease in
2. Dialysis was administered 3 times a week in 36 patients
and twice a week in one patient because this patient had
good residual renal function: mean 24 h urea and creatinine
clearance, greater that 5 mL/min. Dialysis duration was pro-
grammed at 240 min  in 7 patients, 255 min  in 25 patients,
270 min  in 4 patients and 300 min  in one patient. A ﬁstula
was used for dialysis in thirty patients, while the remaining
patients used a tunnelled catheter.
Data from a total of 565 sessions were collected: 192 at
500 mL/min, 194 at 600 mL/min and 179 at 700 mL/min. Ses-
sions with a deviation in prescribed treatment time, Qb  or
sessions with no measurements of K available due to tech-
nical problems were excluded. All patients had undergone at
least 3 sessions with each Qd.
Efﬁcacy  of  dialysis
Results of Kt vs. VI are summarised in Table 1. Kt was
slightly higher if Qd was more  elevated. The opposed was
observed with VI. Kt increased by 1.7% from Qd 500 vs. 600 or
700 mL/min). No differences were observed in Qbe between the
different Qds used, although effective time was one minute
less with a Qd of 700 mL/min.
Mean Ktobj was 49 (4.2) L (36–56.7 L). The comparison
between the achieved Kt and the target Kt is summarised in
Table 1. Kt was much higher than the BSA-adjusted Ktobj for
all Qd. Only one patient did not achieve the Ktobj with any of
the Qds because of vascular access problems.
The 24 L were not achieved in: 2 patients at 500 mL/min
(mean VI: 23.7 L), 2 patients at 600 mL/min (mean VI: 23.8 L),
and in 5 patients at 700 mL/min (VI 23.2 L). Only one patient
had a “low” mean VI (20 L). This was a patient with a bilat-
eral supracondylar amputation and tunnelled central venous
catheter who had trouble achieving a Qb above 350 mL/min.
No statistically signiﬁcant differences were found between
patients achieving and not achieving VI at a Qd = 700 mL/min
(the largest group) nor Kt or effective time, although Qbe
tended to be lower at 376.5 (39.3) vs. 393 (35.2) mL/min. All
patients underwent dialysis using a 5008® monitor.
536  n e f r o l o g i a. 2 0 1 5;3 5(6):533–538
Table 1 – OL-HDF results with different Qd.
Qd Effective time (min) Effective Qb (mL/min) Kt (L) DiffKtobj (L) VI (L)
500 mL/min 246.7 (9.6) 390 (33.6) 61.4 (5.9) 12.4 (6) 27.7 (3.1)****
600 mL/min 246.3 (10) 388.8 (34.7) 62.5 (6.5)** 13.4 (6.4) 27.7 (3.2)*****
700 mL/min 245 (10)* 387.96 (37.0) 62.9 (7.2)*** 13.3 (8) 27.1 (3.4)
DiffKtobj: difference between target Kt and ﬁnal Kt with different Qbs. *p < 0.01 for effective time between 700 and 500–600 mLmin; **p < 0.01
between Kt at 500 and 600 mL/min; ***p < 0.005 between Kt at 500 and 700 mL/min; ****p < 0.009 between VI 700 and 500 mL/min; *****p < 0.012 between
VI at 700 and 600 mL/min.
Table 2 – OL-HDF results in Kt and VI with different
monitors.
Qd Kt (l) VI (l)
AK200 5008 AK200 5008
500 mL/min 59.8 (6.6) 62.7 (5.1) 28.9 (3.1) 26.9 (3)
600 mL/min 60.8 (7) 63.8 (5.9) 29 (3.3) 26.8 (2.8)
700 mL/min 61.1 (7.5) 64.1 (7) 28 (3.3) 26.6 (3.7)
should be disregarded, even more  considering that decreasedData presented as mean (SD).
Differences  between  monitors
Results were stratiﬁed by monitor based on the various meth-
ods used to control convective volume as listed in Table 2. The
trend towards a higher Kt with an elevated Qd was seen with
both monitors. However, in VI, while VIs are similar at any Qd
with Fresenius®, they were slightly lower with Gambro® if a
higher Qd was used.
Dialysate  consumption
The calculated consumption of acid and dialysate in a session
of 255 min  is shown in Table 3. Like this 20% and 40% more
dialysate is required for 600 mL/min and 700 mL/min, respec-
tively, compared to 500 mL/min.
Excessive consumption derived from using 600 or 700 vs.
500 mL/min is depicted in Table 3, not only by patient but
also considering an entire facility like ours with 75 patients.
It should be noted that this consumption refers to dialysate
and not to global water use, which would almost double, as in
order to reach a litre of ultrapure dialysate, between 0.5 and
1 L of water are thrown away during pretreatment.We have partially calculated the cost of a litre of dialysate
(water + acid) to estimate the cost-saving potential. Conse-
quently, the local cost of a litre of dialysate is 0.03 euros with
Table 3 – Dialysis ﬂuid used with different dialysate ﬂows.
Qd Consumed
dialysate (l)
session
Consumed
acid
(l)/session
Annual excess of
dialysate/patient (L)
500 mL/min 127.5 2.8 –
600 mL/min 153 3.4 4.056 
700 mL/min 178.5 3.9 7956 
Annual excess/patient: theoretical consumption of water when using 600 Fresenius and 0.02 with Gambro. The potential cost saving of
decreasing Qd per patient/year is shown in Table 3.
Discussion
The main ﬁnding of our study is the slight improvement in Kt
when increasing Qd in OL-HDF, with practically no effect in
VI. Even though this difference is statistically signiﬁcant, the
clinical relevance of these differences is questionable, even
more when considering that amount of water consumption
that is necessary to achieve this modest result.
There is almost no information available on the use of a
speciﬁc Qd in OL-HDF. A Qd of 700 mL/min is used in most
facilities for increasing the efﬁcacy of diffusive transport, but
there is no rationale for its use. In fact, only one publication
has addressed the effect of Qd in OL-HDF, comparing HD to
OL-HDF by using AutoFlow (AF), a built-in system in the 5008®
monitors where Qd is adjusted to Qb. The authors conclude
that OL-HDF may obtain a higher Kt/V using less dialysate
than in HD.20 But we  have not found reports comparing the
effect of the various Qds on efﬁcacy or VI in OL-HDF, which
makes our study original, and practical. Just as in HD, our
results prove that increasing Qd has a minimal effect on the
efﬁcacy of HD, which is even more  relevant considering that
it is not based on Kt/V calculated from pre- and post-dialysis
urea levels or the V entered to the monitor. Our measure of
dialysis adecuacy is based on the BSA-adjusted Kt, which is a
rigorous assesssement.21 The target was achieved in all except
one patient. In this patient which had vascular access prob-
lem the increase in Qd may not seem to be a useful strategy for
improvement of dialysis adecuacy. This result shows that clas-
sical indications of elevated Qd in OL-HDF to increase efﬁcacymortality resulting from this technique is associated with the
amount of convective volume administered. It could be argued
that the effective time was lower with a Qb = 700 mL/min, and
Annual excess in 75
patients (L)
Saved euros with
Gambro 75
patients/year
Saved euros with
Fresenius 75
patients/year
304,200 9126 6084
596,700 17,901 11,934
or 700 vs. 500 mL/min in litres.
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he achieved Kt would be greater. As extending time is known
o be associated with improved survival irrespective of dialy-
is dose,22 the effect of time loss potentially due to internal
achine controls vs. improved Kt should be balanced, as both
ifferences are not signiﬁcant and possibly irrelevant, and that
s why we believe that using a Qd above 500 mL/min is not an
ffective strategy.
As far as VI, Qd has almost no effect as would have been
nticipated. Automated OL-HDF techniques currently look for
 high-performance convective transport, but each monitor
as different control systems and dissimilar results. In fact,
I is “regulated” based on methods that nephrologists may
ften be unaware of. In any case, elevated Qd has clearly no
ffect or utility to change VI in OL-HDF. After evaluation of
he predetermined objectives it was observed that only one
atient was far from reaching the target 24 L (achieving 20 L)
ecause of problem a poor Qb when undergoing dialysis using
 tunnelled catheter. Interestingly, this patient had a bilateral
upracondylar amputation. At present no BSA-adjusted VI can
e prescribed as in Kt. There is a need to determine what is
he VI target for each patient and to develop a fully individual-
sed OL-HDF. For patients who  were close but did not achieve
he target, this was not dependant of the Qd used. These were
atients whose VI was very close to 24 L, and therefore the tar-
et could possibly be achieved irrespective of Qd by increasing
b or time, or if other methods were used for enhanced per-
ormance. Lastly, many  papers include VI and ultraﬁltration
olume in convective volume. We  have not used the ultraﬁl-
ration volume, which would have helped achieve the target
f 24 L.
We  did not compare Kt or VI resulting from the use of dif-
erent monitors, as this was not the purpose of our study and
t was not designed for this. We believe that the differences
isted in Table 2 in terms of Kt are consistent with the results
eported by Maduell et al., who  showed that ionic dyalisance
alculated by Fresenius monitors was higher as compared
o the AK200® monitor.23 Yet, the higher VI achieved by the
ltracontrol® method is consistent with our results previously
ublished.24
Drinking water for human use is not suitable for produc-
ion of dialysate it has to be puriﬁed. For OL-HDF, the water
nd the dialysate have to be ultrapure independently of the
mount required. Treating a patient for several hours 3 times
 week requires large amounts of water plus consumption of
nergy and the generate undesired throwaway medical prod-
cts. Mean environmental balance per HD session is estimated
t 400–500 L of water, 10 kW/h of electricity, and up to 3 kg
f clinical disposables.25 As a result, in terms of dialysate
anufacturing ultrapure dialysate results in economical and
cological problems. We  have addressed the impact of large
mounts of dialysate; but, particular attention should be paid
o the fact that in order to produce 1 L of dialysate another litre
as lost in the treatment process; i.e., 2 L of water are required
or the generation of 1 L of DF by reverse osmosis, thereby
he consumption is double. Water is essential for life and its
anagement is completely necessary as part of good use of
atural resources; awareness of environmental issues should
e raised among personnel in dialysis facilities. In a 255 min
ession, decreasing the Qd from 700 to 500 mL/min and sav-
ng 51 L of dialysate in each patient may appear irrelevant(6):533–538 537
however more  than 500,000 L of dialysate are required during
one year in a dialysis facility with 75 patients or, as explained
before, this equal to 1,000,000 L of drinking water. In addition,
by maintaining the Qd there is a signiﬁcant amount of acid
is saved with the consequent ﬁnancial and ecological advan-
tage. IN the present study we  have analysed the cost, of 1 L of
dialysate including water and acid, ignoring bicarbonate and
assuming that one cartridge is used per session with inde-
pendently of the Qd used Even though the cost of one litre
seems unimportant at ﬁrst glance, we stress the relevance of n:
annual consumption. Also, in our calculations water used for
preparation or disinfestation has not been included in our cal-
culations (this is why savings could be increased with optimal
use), or other maintenance expenses from the water treat-
ment plant, which may partially be affected by increased water
consumption.
Our study’s main limitation is that the sample size is
small, but the number of dialysis sessions is enough and
the cross-over design allows for comparing each patient with
themselves, which increases the power of results. Our study
had been conducted in a single dialysis facility, but our results
may be extrapolated to all facilities working under similar con-
ditions.
Conclusions
Our data show that increasing Qd above 500 mL/min in OL-
HDF provides a limited advantage. Improving the efﬁcacy of
dialysis by saving water is necessary for our environment and
to meet the current and future human demand for water,
thereby achieving a much more  effective dialysis. Further
studies should be conducted to determine whether or not
using lower Qds is feasible.
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